News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Holsinger Leslie
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Holsinger Leslie (EVP, R&D) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Granted 125,000 options to buy
@ $13.39, valued at
$1.7M
|
|
| 12/15/2020 |
4
| Holsinger Leslie (Executive Vice President) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Sold 1,700 shares
@ $28.8, valued at
$49k
Sold 14,275 shares
@ $30.15, valued at
$430.4k
Sold 13,200 shares
@ $30.91, valued at
$408k
Sold 9,525 shares
@ $31.79, valued at
$302.8k
Sold 400 shares
@ $32.585, valued at
$13k
Sold 900 shares
@ $32.59, valued at
$29.3k
Granted 100,000 options to buy
@ $29.6, valued at
$3M
Exercised 40,000 options to buy
@ $0.27, valued at
$10.8k
|
|
| 12/14/2020 |
4
| Holsinger Leslie (Executive Vice President) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Exercised 3,500 options to buy
@ $0.27, valued at
$945 |
|
| 05/18/2020 |
4
| Holsinger Leslie (Executive Vice President) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Granted 30,000 options to buy
@ $45.88, valued at
$1.4M
|
|
| 02/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|